Sign In
Buy WGS
$63.85
-1.79 (-2.73%)
At Close: Jul 13, 2026
Levi & Korsinsky Investigates Possible Securities Fraud Violations by GeneDx Holdings Corp. (WGS)
06:00am, Tuesday, 11'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerni
An Investigation Has Commenced on Behalf of GeneDx Holdings Corp. Shareholders. Contact Levi & Korsinsky to Discuss your WGS Losses.
05:00am, Tuesday, 11'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerni
GeneDx Holdings Corp. (WGS) Investors with Losses are Urged to Contact Levi & Korsinsky to Discuss Their Rights
02:20am, Tuesday, 11'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerni
ATTENTION GeneDx Holdings Corp. Investors: You May Have Been Affected by Fraud- Contact Levi & Korsinsky to Discuss Your Rights
11:55pm, Monday, 10'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerni
Investors who Lost Money on GeneDx Holdings Corp. Should Contact Levi & Korsinsky about an Ongoing Investigation - WGS
10:00pm, Monday, 10'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerni
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerni
GeneDx Holdings Corp. (WGS) Shareholders May Have Been Affected by Fraud- Levi & Korsinsky Investigates
06:30pm, Monday, 10'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerni
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GeneDx Holdings Corp. ("GeneDx Holdings Corp.") (NASDAQ:WGS) concerni
Bronstein, Gewirtz & Grossman, LLC Encourages GeneDx Holdings Corp. (WGS) Investors to Inquire about Securities Investigation
12:00pm, Monday, 10'th Feb 2025
NEW YORK, NY / ACCESS Newswire / February 10, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of GeneDx Holdings Corp. ("GeneDx" or "the Company") (
GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx announces its launch on Aura, Epic's specialty diagnostics suite, offering advance genetic sequencing within health systems EHR.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of GeneDx Holdings Corp. - WGS
02:30pm, Friday, 07'th Feb 2025
NEW YORK CITY, NY / ACCESS Newswire / February 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of GeneDx Holdings Corp ("GeneDx" or the "Company") (NASDAQ:WGS). Such investors a
GeneDx: Even After Up 2,700% in 2024, Upside Is Still in Play
02:42pm, Friday, 31'st Jan 2025
A little-known stock started to make a huge name for itself in 2024. That stock is GeneDX NASDAQ: WGS.
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04:30pm, Friday, 17'th Jan 2025
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that, effective as of January 14, 2025,
GeneDx Holdings: A Phenomenal Comeback With More Room To Run
02:03am, Thursday, 16'th Jan 2025
GeneDx Holdings Corp. experienced a dramatic turnaround in 2024, achieving profitability and 100x returns, driven by reduced cash burn and strategic product innovations. Key growth catalysts include t
GeneDx Announces Preliminary 2024 Financial Results
08:30am, Monday, 13'th Jan 2025
STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS) today reported preliminary financial results for the fourth quarter and full year of 2024.
